CHF Disease Management 1999 Index
ACE inhibitors
CHF drug therapy getting more complicated, SEP:105
Multiple-drug therapy combats CHF and myths, MAY:52
Angiography/catheterization
Long wait for angiography boosts patient risk, SEP:101
Assessment
Following up on patient assessment, APR:44
Beta-blockers
CHF drug therapy getting more complicated, SEP:105
From beta-blockers to outcomes, the job of a CHF clinician is in the details, JUL:73
More good news for drug therapy with beta-blockers, MAR:27
Researcher says cost not the objective of study, JUL:74
Some points to remember about drug therapy, MAR:29
Cardiomyopathy
TEE for thrombus in dilated cardiomyopathy, NOV:130
Comorbidities
How should you treat comorbidities? OCT:112
Conditioning/physical therapy
Even debilitated patients can improve conditioning, MAR:32
Gentle activity gets patients moving, MAR:34
The Right Stuff, MAR:33
Day care
A word about costs, MAR:31
Use adult day care facilities to full advantage, MAR:30
Depression
Be on the lookout for depression, FEB:18
Go the distance with depression treatment, FEB:19
Use patient's spirituality to fight depression, FEB:21
Diabetes
CHF gets a cameo at ADA Scientific Sessions, AUG:96
Digitalis
CHF drug therapy getting more complicated, SEP:105
Closing in on the ideal digoxin dosage, APR:48
Digitalis revisited, APR:47
There's promising news for digitalis, SEP:105
Discharge
Aggressive discharge plan cuts readmissions, slashes costs, APR:37
CHF discharge activity levels, JUL:82
CHF Home Health Nurse Guidelines, JUL:77
It takes a nurse . . . but what kind? APR:40
Nurses to rein in CHF home care, JUL:76
Study sees intriguing CHF findings Down Under, APR:41
Diuretics
Are your patients OK with K? FEB:17
Your patients can regulate their diuretics at home, FEB:16
Education/information
Experts say success with CHF is now tied to information age, JUN:61
FDA: More information needed on nesiritide, JUN:62
Government pub may be helpful CHF resource, SEP:108
Too many unaware of risk of heart disease, MAY:59
ESRD
Racial equalizers: Insurance, team approach, MAY:54
Generalists vs. specialists
CHF subspecialists outperform generalists, NOV:125
How should you treat comorbidities? OCT:112
More on who manages CHF best: PCPs vs. specialists, NOV:125
The family physician's role in treating CHF, APR:46
Study shows CHF clinics optimize patient care, NOV:127
Study shows CHF patients fare better when cardiologists get involved, OCT:109
Hospices
Consider hospice when other options fail, MAR:31
Hospitalizations
A doctor's wish list for smoother CHF treatment, JAN:6
CDC reports CHF hospitalizations rising, JUL:81
Coming soon: New drug for hospitalized CHF patients, MAY:56
'Grim' prognosis for elderly hospitalized with CHF, MAY:55
Lisinopril
Lisinopril: FDA considers approving higher doses, OCT:113
LVADs
Another perspective on LVAD safety, OCT:117
Researchers seek more bridges to cross with mechanical pumps, FEB:13
Study details risks of LVAD implantation, OCT:115
Surgeons focusing on the mitral valve, MAR:26
Medicare/insurance
Managed care takes a fresh look at CHF, OCT:111
Racial equalizers: Insurance, team approach, MAY:54
The Human Genome Insurance Project, AUG:87
Magnetic resonance imaging
Can MRI diagnose LV dysfunction, blockages better than ultrasound? DEC:133
Cardiac MRI holding its ground, DEC:00
HARP MRI provides fast, clear pictures of heart problems, DEC:135
Muscle hypothesis
Study clarifies exercise intolerance, DEC:138
Nesiritide
Coming soon: New drug for hospitalized CHF patients, MAY:56
FDA: More information needed on nesiritide, JUN:62
New concepts in CHF
Heart failure's shifting paradigms outpace changes in clinical practice, MAR:25
Nursing
CHF Home Health Nurse Guidelines, JUL:77
It takes a nurse . . . but what kind? APR:40
Nurses to rein in CHF home care, JUL:76
Patient compliance
Professional help works with diet compliance, JAN:10
Recognize, head off common compliance issues, JAN:8
Use literature to motivate patient compliance, MAY:53
Pediatrics
Today's kids at risk to be tomorrow's heart patients, MAY:57
Pharmacy
CHF drug therapy getting more complicated, SEP:105
Closing in on the ideal digoxin dosage, APR:48
Coming soon: New drug for hospitalized CHF patients, MAY:56
Digitalis revisited, APR:47
Ensure success by tying in the pharmacist, APR:46
FDA: More information needed on nesiritide, JUN:62
Have you met the new drug on the block? SEP:106
Lisinopril: FDA considers approving higher doses, OCT:113
Milrinone and the clinical challenge of CHF, DEC:142
Monoxadine study halted, NOV:132
More good news for drug therapy with beta-blockers, MAR:27
Multiple-drug therapy combats CHF and myths, MAY:52
New potential for milrinone therapy? DEC:140
Pharmacists do more than fill medicine bottles, JAN:6
RALES study gets the fast track, SEP:102
Some points to remember about drug therapy, MAR:29
There's promising news for digitalis, SEP:105
Pneumococcal polysaccharide vaccine
AMA Alert, JUN:68
Race/gender/age
'Grim' prognosis for elderly hospitalized with CHF, MAY:55
Jackson Heart Study to close the racial divide, SEP:98
Missing: Adequate data on CHF in women, JUN:65
More about the JHS partnership, SEP:100
Multiple-drug therapy combats CHF and myths, MAY:52
Race and sex influence catheterization referral, MAY:50
Racial equalizers: Insurance, team approach, MAY:54
Researchers say current perception of heart patients must be changed, MAY:49
Today's kids at risk to be tomorrow's heart patients, MAY:57
Use literature to motivate patient compliance, MAY:53
Want common ground managing CHF? Close gaps between patients at risk, SEP:97
Women have advantage with some types of CHF, JUN:64
Sleep apnea
Researchers advise physicians: Don't take sleep apnea lying down, JAN:1
Specialized clinics
New Cedars-Sinai clinic to specialize in CHF, APR:43
Research another goal of Cedars CHF center, APR:45
Spironolactone
CHF drug therapy getting more complicated, SEP:105
RALES study gets the fast track, SEP:102
Summer heat
Emphasize importance of fluid control this summer, JUL:81
Technology
New high-tech developments keep CHF patients on right treatment path, AUG:85
RN sees opportunity for professional growth, AUG:95
Swedes say genetics can help tailor treatment, AUG:86
Telephone system supports daily routine, AUG:92
Telemanagement
New high-tech developments keep CHF patients on right treatment path, AUG:85
Setting up a telemanagement system, JAN:4
Telephone system supports daily routine, AUG:92
Three approaches to telemanagement, JUN:66
Time management
Try the big three in time management, JAN:3
TNF
Have you met the new drug on the block? SEP:106
Transplant (heart)
Bone marrow may improve odds for heart recipients, NOV:129
Troponin
TnT could be a dynamite CHF marker, but experts disagree over usefulness, NOV:121
Valves
Surgeons focusing on the mitral valve, MAR:26
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content